pharmacists improving outcomes in patients with diabetes an argument for expansion of scope of...

25
Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Upload: shon-arnold

Post on 12-Jan-2016

215 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Pharmacists improving outcomes in patients with DiabetesAn argument for expansion of scope of practice

Page 2: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Outline

Theory

Diabetes

Pharmacists

Legislation

The Asheville project

Recommendations

Acknowledgements

Page 3: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Theory

The Health Belief Model

Developed by Irwin Rosenstock in 1966 to explain why people used health services.

The first version only had the first 3 points

Subsequent versions have added 4 ,5 and 6

Page 4: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Health Belief Model

1. Perceived Susceptibility

2.Perceived Seriousness

3.Perceived benefits of taking action and perceived barriers to such

4.Perception that benefits outweigh risks

5.Cues to action

6.Perceived self efficacy

Page 5: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Health Belief Model

This theory is especially apt for diabetes

The prognosis depends on the patients ability to do the following things:

Take their medication

Change their behavior ( checking blood sugar regularily)

Change their diet and lifestyle

Before they can make these changes they have to believe in their susceptibility, the seriousness of the disease and have they must have self efficacy

Page 6: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Diabetes

346 million people worldwide have diabetes

25.8 million people (8.3%) in the United States have diabetes

The American Diabetes Association has established goals for treatment

Hemoglobin A1C <7%, blood pressure <130/80 , total cholesterol <200mg/dL

Page 7: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Diabetes

By 2030 the estimate is that 1 in 3 people will have diabetes.

People do not die from diabetes they die from the complications of diabetes

Cardiovascular Disease, kidney disease, blindness ,nerve damage and amputations are complications of diabetes

It is the number one cause of adult onset blindness and end stage renal disease

Page 8: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Diabetes

Total costs for diabetes care were $124 billion nationally (ADA 2012)

Individual employers can spend up to $4410 more per year for each employee with diabetes (Cranor and Christensen 2003)

Costs for patients with diabetes are due to sick days, emergency department visits and hospitalizations for exacerbations and complications.

Page 9: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Diabetes

Only 57% of people with diabetes have met the A1c goal of less than 7%

Only 45% have met the goal of blood pressure less than130/80

Only 46.5% have a total cholesterol of less than 200mg/dL

Only 12.2% are meeting all 3 goals

Page 10: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Pharmacists

Pharmacists are among the most trusted and accessible professionals ( Survey 2012)

They are less expensive than physicians

They are well versed in medication requirements for diabetes

Page 11: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Pharmacists

Pharmacists have been managing patients with diabetes for years in Ambulatory care, Federal facilities and hospitals ( Giberson et al 2011)

Community pharmacists can do it too if given the tools ( Asheville Project 2012)

Currently in California community pharmacists can manage patients with diabetes if they have a Collaborative Practice agreement with a physician.

Page 12: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Legislation

Collaborative Practice Agreement between pharmacist and a physician.

This allows the pharmacist to perform routine drug therapy related assessment

It allows the pharmacists to order related laboratory tests,

It allows the pharmacist to administer drugs and biologicals by injection and initiate or adjust the drug regimen pursuant to physician order or following an established protocol. ( CA Board of Pharmacy 2012)

Page 13: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Legislation

SB1481 went into effect January 2013

Allows the pharmacists to perform heretofore restricted clinical duties without a physicians oversight

Pharmacists are now allowed to conduct certain lab tests as provided by the Clinical Laboratories Improvement Amendment (CLIA) of 1988

Page 14: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Legislation

As long as the pharmacy obtains the certificate of waiver.

The ability to check A1C, blood glucose and cholesterol in the pharmacy would allow the pharmacist to better manage the patients with diabetes

One could check to see if patients are at goal at their first visit and then periodically thereafter.

Page 15: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Legislation

Clinical Pharmacist Practitioner ( CPP)

Established legislation in North Carolina

July 1st 2000

Allows for established pharmacists with Collaborative Practice Agreements to order, change , substitute therapies or order tests according to an established protocol ( Dennis 2012)

Page 16: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Legislation

Pending legislation

SB 493 introduced by Senator Ed Hernadez

Advocates for provider status for pharmacists in California

The bill is intended to allow these highly trained practitioners to practice to the full extent of their abilities and expand access to healthcare in light of the shortage of primary care physicians. ( Hernandez 2013)

Page 17: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Asheville project

A joint project in the city of Asheville, North Carolina

Between the City of Asheville ( the City), University of North Carolina ( UNC), Mission St John Healthcare (MSJ) and the North Carolina Pharmacists Association ( NCPhA)

The project has been running since 1997 and uses Pharmacists as health coaches.

Page 18: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Asheville Project

The patients meet with the pharmacists regularly

Pharmacists in the program have the ability to adjust/change medications as needed.

They also have the ability to order necessary laboratory tests to track patient progress.

The project has yielded marked improvements in A1C, cholesterol and blood pressure ( Mattson 2013)

Page 19: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Asheville Project

Cranor et al 2003

Page 20: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Medical claims/patient costs

$1,000

$3,000

$5,000

$7,000

$9,000

Prior toProgram

1997 1998 1999 2000 2001

Avg

erag

e D

iab

etes

Pat

ien

t C

ost

s P

er Y

ear

Medical Claims Diabetes Rx Other Rx

$7,042

$4,669$4,288 $4,677

$4,129$4,371

Innovations in Quality patient care: The Asheville experience Webb, Michael2013

Page 21: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Compared to US Averages

U.S. Average $7,808 prior to start of program

U.S. Average $7,239 1997

U.S. Average $7,485 1998

U.S. Average $7.762 1999

U.S. Average $8,088 2000

U.S. Average $8,468 2001

Page 22: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Percentage of lab values in optimal range

C

Cranor et al 2003

Page 23: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Recomendations

Passage of SB 493 and introduction and passage of a similar federal bill.

Enhanced use of Collaborative Practice Agreements to allow pharmacists to start to help more patients with diabetes pending passage of this bill.

Recognition of Pharmacists as Non Physician Practitioners ( NPPs) by the Centers For Medicare and Medicaid Services (CMS).

Page 24: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Recommendations

Implementation of the Asheville Project Model ( Healthmaprx) for Diabetes management in all employer and non-employer healthcare plans

Healthmaprx program can be bought and implemented by any organization it is a good value for money and well worth the investment

Funding should be allocated for community and state organizations that cannot afford the implementation fee.

It should be implemented on a federal level by CMS, VA services Indian Health Services and US Public Health Services.

Page 25: Pharmacists improving outcomes in patients with Diabetes An argument for expansion of scope of practice

Acknowledgements

Sally Geisse

Ramon Castelblanch

Mickey Eliason

Nina Wallerstein

Jessica Wolin

Judith Ottoson

Sukdip Purewal

The faculty and Staff of the MPH program

Cohorts 2012, 2013 and 2014